Engineer Cheng Xu

Research Interests:

Biomacromolecular Biomedical Materials.

Research Achievements:

1. Xu, C., Xia, X., Liu, G., Wang, Y. & Xiao, B. Zwitterionic polymers improve the therapeutic effect of silk fibroin-based nanomedicines against ulcerative colitis via the oral route. Precis. Med. Eng. 2, 100027 (2025).

2. Xu, C., Xu, H., Zhu, Z., Shi, X. & Xiao, B. Recent advances in mucus-penetrating nanomedicines for oral treatment of colonic diseases. Expert Opin. Drug Deliv. 20, 1–15 (2023).

3. Ma, Y. et al. Transient Mild Photothermia Improves Therapeutic Performance of Oral Nanomedicines with Enhanced Accumulation in The Colitis Mucosa. Adv. Mater. 36, 2309516 (2023).

4. Yang, W. et al. Mulberry Biomass-Derived Nanomedicines Mitigate Colitis through Improved Inflamed Mucosa Accumulation and Intestinal Microenvironment Modulation. Research 6, 0188 (2023).

5. Liu, G. et al. CaO 2 –Cu 2 O micromotors accelerate infected wound healing through antibacterial functions, hemostasis, improved cell migration, and inflammatory regulation. J. Mater. Chem. B 12, 250–263 (2024).

6. Zhang, J. et al. Transparent silk fibroin films facilitate infected wound healing through antibacterial, improved fibroblast adhesion and immune modulation. J. Mater. Chem. B 12, 475–488 (2024).